当前位置:首页 - 行情中心 - 振东制药(300158) - 财务分析 - 现金流量表

振东制药

(300158)

  

流通市值:75.45亿  总市值:75.50亿
流通股本:10.05亿   总股本:10.05亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,250,597,839.31597,926,743.453,319,611,511.922,479,959,642.53
  收到的税费返还12,665,221.362,202,225.4418,807,255.6918,110,700
  收到其他与经营活动有关的现金20,861,970.382,755,281.946,342,746.4237,318,734.38
  经营活动现金流入小计1,284,125,031.05602,884,250.793,384,761,514.032,535,389,076.91
  购买商品、接受劳务支付的现金555,677,523.68266,383,537.071,578,892,269.371,154,324,604.98
  支付给职工以及为职工支付的现金263,239,406.19105,579,509.57490,614,808.7365,322,889
  支付的各项税费77,070,594.3730,713,845.79202,215,937.81138,552,983.31
  支付其他与经营活动有关的现金791,077,667.14530,217,295.531,262,860,751.24987,961,393.77
  经营活动现金流出小计1,687,065,191.38932,894,187.963,534,583,767.122,646,161,871.06
  经营活动产生的现金流量净额-402,940,160.33-330,009,937.17-149,822,253.09-110,772,794.15
二、投资活动产生的现金流量:
  收回投资收到的现金2,112,499,0001,248,499,0006,346,477,714.165,014,359,360.36
  取得投资收益收到的现金8,895,470.024,157,586.5646,968,868.9735,974,292.76
  处置固定资产、无形资产和其他长期资产收回的现金净额24,266.13-7,770,836.68,833,451.22
  处置子公司及其他营业单位收到的现金净额--988,384.11,032,739.03
  投资活动现金流入小计2,121,418,736.151,252,656,586.566,402,205,803.835,060,199,843.37
  购建固定资产、无形资产和其他长期资产支付的现金68,305,950.7726,579,151.77298,476,228.4232,144,683.74
  投资支付的现金1,708,003,000967,003,0006,064,217,554.345,001,922,654.68
  投资活动现金流出小计1,776,308,950.77993,582,151.776,362,693,782.745,234,067,338.42
  投资活动产生的现金流量净额345,109,785.38259,074,434.7939,512,021.09-173,867,495.05
三、筹资活动产生的现金流量:
  取得借款收到的现金--38,109,647.779,310,461.58
  收到其他与筹资活动有关的现金26,254,686.721,766,957.9991,850,241.3161,065,477.54
  筹资活动现金流入小计26,254,686.721,766,957.99129,959,889.0870,375,939.12
  偿还债务支付的现金30,637,400150,00053,350,00050,200,000
  分配股利、利润或偿付利息支付的现金148,348.2182,462.2584,652.53505,767.83
  支付其他与筹资活动有关的现金66,636,021.1161,638,214.31170,518,396.79155,277,181.63
  筹资活动现金流出小计97,421,769.3261,870,676.51224,453,049.32205,982,949.46
  筹资活动产生的现金流量净额-71,167,082.62-40,103,718.52-94,493,160.24-135,607,010.34
五、现金及现金等价物净增加额-128,997,457.57-111,039,220.9-204,803,392.24-420,247,299.54
  加:期初现金及现金等价物余额558,015,272.49558,015,272.49762,818,664.73762,818,664.73
  期末现金及现金等价物余额429,017,814.92446,976,051.59558,015,272.49342,571,365.19
补充资料:
  净利润6,503,597.16--1,332,939,095.45-
  资产减值准备10,736,851.69-290,875,553.09-
  固定资产和投资性房地产折旧44,037,416.92-92,889,781.6-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧44,037,416.92-92,889,781.6-
  无形资产摊销11,977,974.05-20,679,341.22-
  长期待摊费用摊销3,711,433.62-5,475,613.69-
  处置固定资产、无形资产和其他长期资产的损失-4,604.73--11,256,735.65-
  固定资产报废损失-24,016.13-712,593.1-
  公允价值变动损失-1,328,710.16-139,440,121.7-
  财务费用1,230,174.45-3,900,426.39-
  投资损失-6,519,141.08--41,972,827.58-
  递延所得税1,084,921.23--3,275,343.82-
  其中:递延所得税资产减少966,779.54--3,957,060.89-
    递延所得税负债增加118,141.69-681,717.07-
  存货的减少185,984,818.62-176,504,093.1-
  经营性应收项目的减少-170,981,671.02-114,995,475.58-
  经营性应付项目的增加-488,884,420.51-270,363,450.63-
  其他-464,784.44-122,768,092-
  现金的期末余额429,017,814.92-558,015,272.49-
  减:现金的期初余额558,015,272.49-762,818,664.73-
  现金及现金等价物的净增加额-128,997,457.57--204,803,392.24-
公告日期2025-08-252025-04-212025-04-212024-10-24
审计意见(境内)标准无保留意见
TOP↑